MyFinsight
Home
About
Contact
Download
Download image
Comprehensive loss
-$31,333K
(-6.13%↓ Y/Y)
Net loss
-$31,333K
(-6.13%↓ Y/Y)
Other income, net
$677K
(-57.26%↓ Y/Y)
Collaboration Revenue
$46,650K
Product
$40,659K
Interest expense
$22,051K
(46.21%↑ Y/Y)
(loss) income from
operations
-$9,959K
(37.86%↑ Y/Y)
Total revenues
$87,309K
(69.10%↑ Y/Y)
Total operating
expenses
$97,268K
(43.76%↑ Y/Y)
Selling, general and
administrative
$41,848K
(4.69%↑ Y/Y)
Research and development
$14,131K
(35.91%↑ Y/Y)
Cost of goods sold
$41,289K
(138.86%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
espr: the income statement
Esperion Therapeutics, Inc. (ESPR)
Esperion Therapeutics, Inc. (ESPR)